Following are approved statements by the Alzheimer's Association National Board of Directors or the Alzheimer's Association Medical and Scientific Advisory Group. These statements provide the Association's positions around ethical, medical and care topics related to Alzheimer's disease or dementia. Statements are based on relevant research, best practice and expert opinion at the time of statement development.

• Cannabis and Cannabis-Derived Products (PDF)
• Dementia-Related Behaviors (PDF)
• Diagnosis Disclosure (PDF)
• Dietary Supplements and Medical Foods (PDF)
• Driving and Dementia (PDF)
• Electronic Tracking (PDF)
• End-of-Life Care (PDF)
• Feeding Issues in Advanced Dementia (PDF)
• Generic Drugs and Alzheimer's Disease (PDF)
• Genetic Testing (PDF)
• LGBTQ+ and Dementia (PDF)
• Placebo Control (PDF)
• Protection of Participants in Research (PDF)
• Research Using Stem Cells (PDF)
• Respect for Autonomy (PDF)
• Right to Treatment (PDF)
• Use of Animals in Research (PDF)